Content - Volume 99, Issue 11
You can find all new content after October 1 on our new website, you can find it
here.
Editor's choice in this issue
CLINICAL REPORT
Malin Engfeldt, Marléne Isaksson, Bo Glas, Lina Hagvall, Anna Löfnertz Petersson, Mihály Matura, Berndt Stenberg, Cecilia Svedman, Magnus Bruze
A new mercaptomix (3.5%), containing 2-mercaptobenzothiazole (MBT) 2.0% instead of 0.5%, has been tested in over 3000 dermatitis patients in 5 Swedish dermatology departments simultaneously with MBT 2.0% and mercaptomix 2.0%. Results showed that mercaptomix 3.5% detected all positive patients and more patch-test positive patients than the other two substances did. The Swedish Contact Dermatitis Research Group will recommend that mercaptomix 3.5% replaces MBT 2.0% and mercaptomix 2.0% in the Swedish baseline series from 2020.
Pages: 960-963
CLINICAL REPORT
Grigorios Theodosiou, Scott Montgomery, Alexandra Metsini, Florence J. Dalgard, Åke Svensson, Laura B. von Kobyletzki
The burden of atopic dermatitis (AD) was assessed in a population-based, cross-sectional questionnaire study among 34,313 Swedish adults. The reported prevalence of AD was 14%. AD, especially when severe, was associated with an increased prevalence of depression, anxiety and a lower academic achievement and occupational status.
Pages: 964-970
All articles
REVIEW
Helen Rea, Brian Kirby
Microdialysis is a minimally invasive technique to study metabolic, biochemical, and pharmacological events in tissue. Factors that influence microdialysate collection include molecular weight cutoff of the membrane, perfusion rate, perfusate viscosity, duration of collection, depth of the catheter, length of the tubing and adsorption of hydrophobic molecules to the membrane. To standardize these ...
Pages: 945-952
CLINICAL REPORT
Tao Wang, Min Zhang, Ying Zhang, Yu Zhang, Shiyu Zhang, Tao Qu, Yuehua Liu, Hongzhong Jin
Wolf’s isotopic response refers to the occurrence of a new skin disease at the exact site of an unrelated skin disease that had previously healed. Various cutaneous lesions have been described after herpes zoster. This study included 24 patients with Wolf’s isotopic response after herpes zoster infection, which presented as manifestations ranging from inflammatory disease to carcinoma. Histopa ...
Pages: 953-959
CLINICAL REPORT
Malin Engfeldt, Marléne Isaksson, Bo Glas, Lina Hagvall, Anna Löfnertz Petersson, Mihály Matura, Berndt Stenberg, Cecilia Svedman, Magnus Bruze
This study investigated whether more patients with contact allergies were detected by patch testing with mercapto mix with a higher concentration of 2-mercaptobenzothiazolinone (MBT) than the commonly used mercapto mix. A total of 3,143 dermatitis patients in 5 Swedish dermatology departments were patch- tested with 3 mercapto test preparations: MBT 2.0% petrolatum (pet.); mercapto mix 2.0% pet.; ...
Pages: 960-963
CLINICAL REPORT
Grigorios Theodosiou, Scott Montgomery, Alexandra Metsini, Florence J. Dalgard, Åke Svensson, Laura B. von Kobyletzki
The burden of atopic dermatitis (AD) was assessed. A population-based, cross-sectional questionnaire study was performed among 34,313 Swedish adults in 2017. The prevalence of AD was 14%. Adults with mild AD had an increased relative risk ratio (RRR) of severe depression (aRRR 1.78, 95% confidence interval (95% CI) 1.50–2.12) and anxiety (aRRR 1.97, 95% CI 1.69–2.30), which was higher for seve ...
Pages: 964-970
CLINICAL REPORT
Luís Puig, Martin Dossenbach, Lovisa Berggren, Anders Ljungberg, Claus Zachariae
Treatment goals defined by the absolute Psoriasis Area and Severity Index (PASI) scores offer certain advantages in the clinical setting. In order to investigate potential treatment targets, this study evaluated absolute PASI outcomes relative to other measures of response using data from two randomized clinical trials of patients with moderate-to-severe psoriasis treated with ixekizumab, etanerce ...
Pages: 971-977
CLINICAL REPORT
Veronique Touzeau-Roemer, Michael Skoll, Pooja Tajpara, Philip Kienzl, Antonia Wesinger, Simona Saluzzo, Martin Bauer, Maximilian C. Aichelburg, Christine Bangert, Wolfgang Bauer, Georg Stingl, Armin Rieger, Katharina Grabmeier-Pfistershammer, Christopher Schuster
Various autoantibodies are detected more frequently in HIV-infected individuals than in HIV-negative controls; however, limited data exist regarding autoimmune blistering skin diseases. Using enzyme-linked immunoassay (ELISA) and indirect immunofluorescence, no difference in the frequency and magnitude of autoantibodies against BP180, BP230, desmoglein 1 and 3 was found between 594 HIV-infected ...
Pages: 978-983
CLINICAL REPORT
Hyo Jung Kim, Ju Hee Han, Chul Hwan Bang, Kyung Shin Park, Seok-Goo Cho, Dong Su Yoo, Kyung Moon Kim, Hyun Jung Park, Young Min Park, Jun Young Lee, Ji Hyun Lee
Castleman’s disease is a rare disease of the lymph nodes and related tissues, presenting as angiofollicular or giant lymph node hyperplasia. Although various skin manifestations have been reported to occur in Castleman’s disease, a comprehensive study of cutaneous disorders in Castleman’s disease is lacking. Therefore, the aim of this study was to investigate Castleman’s disease-associated ...
Pages: 984-989
CLINICAL REPORT
Shira Sandbank, Vered Molho-Pessach, Adam Farkas, Aviv Barzilai, Shoshana Greenberger
Vascular anomalies (VAs) may be associated with significant morbidity and mortality. The aim of this study was to evaluate the efficacy and safety of sirolimus (rapamycin) in the treatment of children and young adults with complicated VAs. A retrospective chart was created that included 19 patients treated with sirolimus for complicated VAs. Concurrently, a search of the PubMed database for VA cas ...
Pages: 990-996
CLINICAL REPORT
Youming Mei, Wenyue Zhang, Ying Shi, Haiqin Jiang, Zhiming Chen, Santosh Chokkakula, Siyu Long, Chun Pan, Hongsheng Wang
To identify the microorganism distribution clinical characteristics and management of cutaneous Mycobacterium tuberculosis and nontuberculous mycobacterial infectious diseases in the past 10 years we collected and analyzed the patient records of all cutaneous M. tuberculosis and nontuberculous mycobacterial infection cases diagnosed by culture and/or PCR from 2008 to 2017 in the Hospital of Dermat ...
Pages: 997-1003
INVESTIGATIVE REPORT
Lies Lambrechts, Liesbeth Gilissen, Marie-Anne Morren
Corticophobia is a major problem in adherence to therapy. This study examined corticophobia among healthcare professionals using the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The TOPICOP questionnaire was adapted for use with professionals (TOPICOP-P). Four groups of professionals: pharmacists, paediatricians, general practitioners and dermatologists were observed. The mean global TOP ...
Pages: 1004-1008
INVESTIGATIVE REPORT
Manuel P. Pereira, Konstantin Agelopoulos, Johannes Köllner, Gitta Neufang, Martin Schmelz, Sonja Ständer
Central sensitization induces pain augmentation in chronic pain states. An analogous mechanism is speculated for chronic pruritus. This study compared patients with chronic pruritus (n = 79) of different origins (atopic dermatitis, chronic pruritus on non-lesional skin, chronic prurigo) and healthy controls (HC, n = 54) with regard to itch intensity and qualities of sensory symptoms after ...
Pages: 1009-1015
INVESTIGATIVE REPORT
Radomir Reszke, Rafał Białynicki-Birula, Karolina Lindner, Małgorzata Sobieszczańska, Jacek C. Szepietowski
Ageing is associated with numerous medical afflictions, including dermatological symptoms and diseases. Chronic itch (CI) in elderly people is a frequent symptom of diverse aetiology. This study assessed the prevalence and detailed clinical features of CI among 153 elderly patients hospitalized in the geriatric ward, including associations with comorbidities and pharmacotherapy. CI affected 35.3% ...
Pages: 1016-1021
INVESTIGATIVE REPORT
Yimeng Wang, Weiwei Li, Qian Zhang, Xiaoguang Gu, Xinglan He, Yuehua Men, Chunlei Zhang
Cutaneous T-cell lymphoma (CTCL) represents a rare group of extranodal T-cell lymphoproliferative diseases. Due to poor clinical outcome of CTCL, there is an urgent need for new and improved therapies. A small molecule, IPA-3, which inhibits p21-activated kinase 1 (PAK1), has shown therapeutic potential in various types of malignancies. In the present study, the anti-tumor effect of IPA-3 and its ...
Pages: 1022-1028
SHORT COMMUNICATION
Franziska Schauer, Holger Steinke, Kaethe Thoma, Dimitra Kiritsi
Abstract is missing (Short communication)
Pages: 1029-1030
SHORT COMMUNICATION
Gil Yosipovitch, Yan Dong, Russel Burge, Baojin Zhu, David Shrom, Alexa B. Kimball
Abstract is missing (Short communication)
Pages: 1031-1032
SHORT COMMUNICATION
Paul Cirotteau, Philippine Lucas, Léa Dousset, Valérie Cales, Olivier Gilliot, Thomas Jouary
Abstract is missing (Short communication)
Pages: 1033-1034
SHORT COMMUNICATION
Isabella Weimar, Pernille Ommen, Lars Iversen, Claus Johansen
Abstract is missing (Short communication)
Pages: 1035-1036
SHORT COMMUNICATION
Nikolai Dyrberg Loft, Christian Harbo Andersen, Anne-Sofie Halling-Overgaard, Jacob P. Thyssen, Lone Skov, Alexander Egeberg
Abstract is missing (Short communication)
Pages: 1037-1038
SHORT COMMUNICATION
Tomonori Oka, Tomomitsu Miyagaki, Hiroaki Kamijo, Rina Nakajima, Naomi Shishido-Takahashi, Naoyuki Senda, Hiraku Suga, Makoto Sugaya, Shinichi Sato
Abstract is missing (Short communication)
Pages: 1039-1040
SHORT COMMUNICATION
Jana Dorothea Braun, Cyrill Géraud, Alexander Marx, Andreas Reiter, Mohamad Jawhar, Jan P. Nicolay
Abstract is missing (Short communication)
Pages: 1041-1042
SHORT COMMUNICATION
Theresa Steeb, Anja Wessely, Lars E. French, Markus V. Heppt, Carola Berking
Abstract is missing (Short communication)
Pages: 1043-1044
SHORT COMMUNICATION
Francesca Satolli, Maria Beatrice de Felici del Giudice, Mariabeatrice Bertolani, Roberto Ricci, Torello Lotti, Alfredo Zucchi, Claudio Feliciani
Abstract is missing (Short communication)
Pages: 1045-1046
SHORT COMMUNICATION
Syed Mohammad Husain Rizvi, Marit B. Veierød, Gro Mørk, Per Helsing, Petter Gjersvik
Abstract is missing (Short communication)
Pages: 1047-1048
SHORT COMMUNICATION
Hua-Ching Chang, Chih-Wei Sung, Ming-Hsiu Lin
Abstract is missing (Short communication)
Pages: 1049-1050
SHORT COMMUNICATION
Sandra Gouveia-Figueira, Karin Danielsson, Christopher J. Fowler
Abstract is missing (Short communication)
Pages: 1051-1052
CORRESPONDENCE
Francesco Drago, Giulia Ciccarese, Aurora Parodi
Abstract is missing (Correspondence)
Pages: 1053-1054
QUIZ
Ioannis Spyridis, Chryssoula Papageorgiou, Zoe Apalla, Aimilios Lallas
Abstract is missing (Quiz)
Pages: 1055-1056
QUIZ
Kazuki M. Matsuda, Kouki Nakamura, Maasa Kobayashi, Hiraku Suga, Shinichi Sato
Abstract is missing (Quiz)
Pages: 1057-1058
QUIZ
Jia-Qi Lv, Yue-Ping Zeng, Tao Qu
Abstract is missing (Quiz)
Pages: 1059-1060
QUIZ
Stefano Veraldi, Gianluca Nazzaro
Abstract is missing (Quiz)
Pages: 1061-1062
QUIZ
Gianluca Nazzaro, Paolo Bortoluzzi, Stefano Veraldi, Emilio Berti
Abstract is missing (Quiz)
Pages: 1063-1064
QUIZ
Rikke Maria Nielsen, Anette Bygum
Abstract is missing (Quiz)
Pages: 1065-1066